Latest Competition News

High Peak Royalties has fully repaid its US$750,000 financing facility with Macquarie Bank, removing all associated securities and guarantees. The company signals confidence in its near-term liquidity and operational funding.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

KneoMedia reports a successful quarter marked by significant capital raises and expanding deployments of its KneoScience platform across New York City schools, positioning the company for sustained revenue growth.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.

AUCyber Limited has received a conditional takeover proposal from Interactive Pty Ltd at $0.165 per share, prompting a careful board review against a competing offer from 5GN.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.

BlinkLab has launched its pivotal FDA registrational study for its AI-driven autism diagnostic app, BlinkLab Dx 1, following positive FDA feedback and promising preliminary results.

Impact Minerals Limited reported its December 2024 quarterly cash flow, revealing ongoing exploration expenditures and a significant $2.87 million grant to commercialise its High Purity Alumina process at Lake Hope.

Firebird Metals Limited has secured preliminary design approval for its battery-grade manganese sulphate plant in China and forged a strategic partnership to develop LMFP cathode materials, marking significant progress in its EV battery ambitions.

Bluechiip Limited remains in ASX suspension as it finalises its 2024 audited accounts, while its ongoing Strategic Review and BioLife deal set the stage for a pivotal 2025 focused on revenue growth and cash-flow break-even.

Midas Minerals reports steady progress in its Western Australian gold and base metals projects alongside a $1.6 million capital raising, positioning the company for upcoming drill target definitions.